China Healthcare ETF (KURE) Hits New 52-Week High
Zacks Investment Research | May 15, 2020 07:40AM ET
Investors seeking momentum may have KraneShares MSCI (NYSE:MSCI) All China Health Care Index ETF KURE on radar now. The fund recently hit a new 52-week high. Shares of KURE are up approximately 50.02% from their 52-week low of $18.49/share.
But could there be more gains ahead for this ETF? Let’s take a look at the fund and the near-term outlook to get a better idea of where it might be headed.
KURE in Focus
The underlying MSCI China All Shares Health Care 10/40 Index is a free float adjusted market capitalization weighted index designed to track the equity market performance of Chinese companies engaged in the health care sector. KURE charges investors 65 basis points in fee per year (see all Asia-Pacific (Emerging) ETFs here).
Why the move?
Healthcare and biotech stocks and ETFs gained globally amid the ongoing medical emergency. China is no exception. China’s healthcare and biotech firms have raised a record $6.8 billion in fresh equity-linked transactions this year, per Reuters.
China’s healthcare expenditure made up only 6.6% of its GDP in 2018, compared with 17.7% in the United States, per Reuters. So, COVID-19 raised the importance of investing more in the Chinese healthcare system.
In any case, the Chinese biopharmaceutical and healthcare industry is thriving with opportunities right now. China is a big market with about $1.26 billion population, which has always been a point of interest for both Chinese and Western providers of drugs.
More Gains Ahead?
The fund has a weighted alpha of 39.26 . So, there is a decent outlook ahead for those who want to ride this surging ETF a shade further.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.